US breast cancer drug decision 'marks start of death panels' - Telegraph
"America's health watchdog is considering revoking its approval of the drug Avastin for use on women with advanced breast cancer, leading to accusations that it will mark the start of 'death panel' drug rationing."
No comments:
Post a Comment